Navigation Links
Cadence Pharmaceuticals' CEO Ted Schroeder to Present at Three Investment Conferences During the Month of May 2011
Date:4/26/2011

SAN DIEGO, April 26, 2011 /PRNewswire/ -- Cadence Pharmaceuticals, Inc. (NASDAQ: CADX), a biopharmaceutical company focused on in-licensing, developing and commercializing proprietary products principally for use in the hospital setting, announced today that the company's President and CEO Theodore Schroeder will present a corporate overview at the following investment conferences during the month of May:

  • Deutsche Bank's 36th Annual Health Care Conference at the InterContinental Hotel in Boston on Tuesday, May 3, 2011 at 3:30pm Eastern Time (12:30pm Pacific Time)
  • Bank of America Merrill Lynch 2011 Health Care Conference at the Wynn Hotel in Las Vegas on Wednesday, May 11, 2011 at 4:40pm Eastern Time (1:40pm Pacific Time)
  • UBS Global Specialty Pharmaceuticals Conference 2011 at the UBS office in London on Tuesday, May 24, 2011 at 3:30am Eastern Time (12:30am Pacific Time).

  • Each presentation will be simultaneously webcast and can be accessed on Cadence Pharmaceuticals' website at www.cadencepharm.com in the Investor Relations section.  A replay of each webcast will be available approximately three hours after the live webcast concludes and will remain available for 30 days.

    About Cadence Pharmaceuticals, Inc.Cadence Pharmaceuticals is a biopharmaceutical company focused on in-licensing, developing and commercializing proprietary products principally for use in the hospital setting. For more information about Cadence, please visit www.cadencepharm.com. Contacts:

    William R. LaRue

    SVP, CFOCadence Pharmaceuticals, Inc.

    858-436-1400
    '/>"/>

    SOURCE Cadence Pharmaceuticals, Inc.
    Copyright©2010 PR Newswire.
    All rights reserved

    Page: 1

    Related medicine technology :

    1. Cadence, Inc. Expands Executive Team
    2. Cadence Pharmaceuticals Reports Fourth Quarter and Full Year 2010 Financial Results
    3. Cadence Pharmaceuticals CEO Ted Schroeder to Present at the Cowen and Company 31st Annual Health Care Conference in Boston on March 9, 2011
    4. Cadence Pharmaceuticals to Present at Two Investment Conferences in February 2011
    5. AccessClosure Announces Launch of New Mynx Cadence™ Vascular Closure Device
    6. Cadence Pharmaceuticals Announces Pricing of Public Offering of Common Stock
    7. Cadence Pharmaceuticals Reports Third Quarter 2010 Financial Results
    8. Cadence Pharmaceuticals to Host Conference Call and Webcast to Discuss Third Quarter 2010 Financial Results on November 5, 2010
    9. Cadence Pharmaceuticals to Present at Four Investment Conferences During the Month of September 2010
    10. Oxford Finance Corporation Leads $30 Million Secured Loan Facility for Cadence Pharmaceuticals
    11. Cadence Pharmaceuticals Announces FDA Extends New Drug Application Review for Intravenous Acetaminophen by Three Months
    Post Your Comments:
    *Name:
    *Comment:
    *Email:
    (Date:3/3/2015)... NEW YORK , March 3, 2015  This industry report package ... and future outlook for safety glass in the world and in the ... the package includes country reports from the following countries: ... , Germany , Italy , ... Turkey , United Kingdom , United ...
    (Date:3/3/2015)... 2015  UnaliWear announces the market preview of its ... that guards against wandering and provides support for falls ... – the Kanega watch ( http://www.UnaliWear.com ) – is ... easy speech interface rather than buttons, use cellular and ... The watch goes wherever the wearer ...
    (Date:3/3/2015)...  Columbia Laboratories, Inc. (Nasdaq: CBRX ) ... specialty pharmaceutical company focused on pharmaceuticals for women,s health, ... Annual ROTH Conference, which will take place from March ... Dana Point, California . Management,s presentation will take ... Time (12:00 p.m. Eastern Time) in the Promenade room. ...
    Breaking Medicine Technology:Global Safety Glass Market to 2019 - Market Size, Top 10 Countries, Trends, and Forecasts 2UnaliWear's Wearable For Seniors Extends Independence With Advanced Technology 2
    ... Sept. 19 A new topical lotion that,penetrates ... serious skin,infections, but without being systemically absorbed, has ... patients with onychomycosis, or,toenail fungus, a new study ... clinical trial are important to the fields of,dermatology ...
    ... Targanta,s Novel Drug Discovery Platform, CHICAGO, Sept. ... from two studies highlighting the in vitro,activity and ... osteomyelitis,models. Results are being presented today at the ... (ICAAC) taking place in,Chicago, IL and represent the ...
    Cached Medicine Technology:New Topical Therapy Safely Treats Serious Skin Infections Without Systemic Side Effects 2New Topical Therapy Safely Treats Serious Skin Infections Without Systemic Side Effects 3Targanta Presents First Data Demonstrating In Vitro Activity and In Vivo Efficacy of Prodrugs in Osteomyelitis Models 2Targanta Presents First Data Demonstrating In Vitro Activity and In Vivo Efficacy of Prodrugs in Osteomyelitis Models 3
    (Date:3/4/2015)... Professionals with disabilities are eager to ... companies, according to a new Think Beyond the Label ... 235 professionals with disabilities , respondents also say they ... including ones that are geared to people with disabilities, ... ,     Online job search tools are used by ...
    (Date:3/4/2015)... 04, 2015 The medical device landscape ... management forgot – or ignored or didn't know – ... market based on physician input before proceeding to design ... specifically, founders – become so enamored of an innovative ... Will physicians use the device?” says Dr. Kathryn ...
    (Date:3/3/2015)... Anik Singal's Profit Academy - ... marketers has become the talk of the town ... surrounding the course's general release has garnered the ... her to review the program's content and publish ... biggest keys to success with Internet marketing is ...
    (Date:3/3/2015)... March 03, 2015 On February 21st, ... the fabulous EcoLuxe Lounge, a day-long event that features ... conscious products and services. Organized by Debbie Durkin and ... film placement producer, the EcoLuxe Lounge saw many notable ... roles on General Hospital, The Flash, Star Trek: Deep ...
    (Date:3/3/2015)... March 03, 2015 Findings could lead ... at UC Davis have developed and characterized a molecule ... causing them to self-destruct. This novel mechanism was found ... a usually fatal type of brain cancer – and ... , The article, to be published in the April ...
    Breaking Medicine News(10 mins):Health News:Job Seekers with Disabilities Seek Targeted Outreach from Employers and Online Job Search Tools, says New Think Beyond The Label Survey 2Health News:Job Seekers with Disabilities Seek Targeted Outreach from Employers and Online Job Search Tools, says New Think Beyond The Label Survey 3Health News:Want to Succeed in Medical Technology? Don't Innovate in a Vacuum 2Health News:Want to Succeed in Medical Technology? Don't Innovate in a Vacuum 3Health News:Anik Singal's Profit Academy - Review Of New IM Training Program Released 2Health News:Hollywood Star Chase Masterson and Choices Recovery Discuss Substance Abuse and Treatment at 2015 Oscars 2Health News:News: UC Davis Scientists Describe Novel Drug Mechanism That Fights Brain Cancer 2Health News:News: UC Davis Scientists Describe Novel Drug Mechanism That Fights Brain Cancer 3Health News:News: UC Davis Scientists Describe Novel Drug Mechanism That Fights Brain Cancer 4
    ... could actually be caused as a result of a defect ... after scientists have worked towards identifying important skin cancer genes ... scientists to look at thousands of genes at once, helping ... greater detail. There are over 200 different types of cancer ...
    ... ketoacidosis (DKA) is a life-threatening condition that frequently ... The critical factors in the treatment of DKA ... skillful fluid and electrolyte adjustment, and the initiation ... fluid volume has been achieved. Continuous low-dosage intravenous ...
    ... Anderson Cancer Center have found that weight gain or ... of prostrate cancer. ,The report is detailed in ... Research, corroborates findings of an earlier research that had ... Strom, Ph.D., an associate professor in the Department of ...
    ... Phase II study to 12 months confirm the significant effects ... patients with relapsing multiple sclerosis (MS). ,The data, ... both patient groups taking FTY720 (1.25 mg and 5 mg) ... of more than 50% during the first six months of ...
    ... chronic illness that requires continuing medical care and ... to reduce the risk of long-term complications//. As ... care practitioners are confronted with an ever-increasing tide ... Undiagnosed chronic kidney disease (CKD) is common in ...
    ... an ancient myth that coco bean can be used to treat ... limit the development of fluids that cause diarrhea//. ,The use ... 16th century by ancient South American and European cultures. Until now, ... bean or more specifically why it has been used in the ...
    Cached Medicine News:Health News:Novartis MS Drug Shows Promising Results 2Health News:Novartis MS Drug Shows Promising Results 3
    ... a liver-specific contrast agent approved for sale ... introduction expands the Amersham Health portfolio to ... intravenously, TESLASCAN aids in the detection, localization, ... can begin within minutes of injection, and ...
    ... a new Contrast Agent for ... of stabilized SF6 microbubbles. The ... between 1 and 10 m, ... 2 and 5 x 108 ...
    ... is the only isosmolar contrast medium (IOCM™) available ... that of blood, VISIPAQUE was designed for patient ... contrast medium formulated with sodium and calcium in ... received FDA approval for use in children over ...
    The cordless Simon Dermatome with rechargeable battery is used to harvest split-thickness skin grafts and for debridement....
    Medicine Products: